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a b s t r a c t
We describe a young male who had undergone a Bentall's procedure seven years ago
presenting with acute severe chest pain. He was diagnosed to have coronary embolism
from prosthetic heart valve thrombosis. Multiple treatment strategies for the patient were
available and we brieﬂy discuss the merits of each of them. We also describe the encoun-
tered difﬁculties in the percutaneous revascularization procedure.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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A 20-year-old male presented to us with chest pain of 6 h
duration. Previously, he was diagnosed to have bicuspid aortic
valve with severe aortic stenosis with aortic regurgitation and
coarctation of aorta with severe left ventricular dysfunction. A
balloon dilatation of coarctation of aorta was performed
initially followed by a Bentall's procedure (replacement of
aortic arch with aortic valve and implantation coronaries on
the trunk) with a St. Jude's bileaﬂet metallic prosthetic valve
(St. Jude Medical, Inc. MN, USA) size 24. He developed complete
heart block postoperatively for which a DDDR pacemaker was
given. During the current admission, he presented with acute* Corresponding author.
E-mail address: drsnboopathy@gmail.com (N.B. Senguttuvan).
http://dx.doi.org/10.1016/j.ihj.2015.10.372
0019-4832/# 2015 Cardiological Society of India. Published by Elsevierchest pain and breathlessness of 6 h duration that was not
radiating to back. He was on regular dosages of Acitrom 3 mg
per day. But he was having irregular clinical visit and his last
INR was 2.5, done a few months ago. His current INR was 2.0.
On examination, his heart rate was 126/min, and blood
pressure was 80/60 mmHg without any BP difference between
the limbs or murmurs in chest. His systemic examination
revealed a good valve click with bilateral basal creptations
occupying >50% of both the lung ﬁelds. His electrocardiogram
showed evidence of atrial sensing and ventricular pacing
without any signiﬁcant ST elevation in the leads (not s/o of
acute MI as per Sgarbossa's criteria). Considering the clinical
presentation, possibilities of aortic dissection (AD) and acute
coronary syndrome (ACS) were considered. Though BAV B.V. All rights reserved.
Fig. 2 – Left coronary angiogram in right anterior oblique
caudal view showing complete occlusion of circumflex
after OM1. The stump of the lesion is seen.
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deformity of aorta in such patients may extend into arch
and thoracic segments leading to dissection or aneurysm of
such segments especially in a patient who has undergone
Bentall surgery. A contrast enhanced CT angiogram showed
complete occlusion of left circumﬂex artery with no evidence
of AD. Though TEE might have been useful, it was not
contemplated as the patient has got a Bentall's procedure, and
visualization of the junction of graft to tissue would have been
difﬁcult to identify any dissection ﬂaps at that site. A
transthoracic echocardiogram (TTE) done showed severe LV
dysfunction (Ejection fraction of 20–25%) with hypokinesia in
the infero-posterior region and mean gradient of 28 mmHg
across the aortic valve. An initial cine-ﬂuroscopy revealed mild
restriction of one of the leaﬂets of aortic valve (Video 1). Finally,
a diagnosis of prosthetic heart valve thrombosis (PHVT) with
coronary embolism was made.
Considering his ongoing chest pain, severe LV dysfunction
with acute pulmonary edema, primary PCI was considered. The
most important challenge is to avoid iatrogenic catheter
induced embolism of the thrombus in the aortic valve. The
other was hooking of the coronary artery that had been
implanted on the aortic graft. The former challenge was tackled
by controlled, gentle, minimal motion of catheters inside the
root so as to avoid the catheter contacting with the aortic valve.
Pre-procedural computerized tomography of aorta and coronar-
ies (CT) was very useful in this process of cannulating the
guiding catheter to the left coronary system (Fig. 1). We were
able to hook the left coronary artery with XB catheter (Cordis,
Johnson and Johnson, USA). Coronary angiogram showed a
normal left anterior descending artery with a completely
occluded left circumﬂex artery system with a small stump
with lots of thrombus load (Fig. 2 and Video 2). The lesion was
crossed with a Crosswire NT (Terumo Medical Corporation, NJ)Fig. 1 – CT angiogram with sagittal oblique planar shows the
Bentall's procedure (valve marked with black arrow and
homograft indicated with arrowhead) with dilatation of the
left coronary artery button (white arrow).guidewire following which it was ballooned with a 2 mm balloon
(Fire Star, Cordis, Johnson and Johnson). Initially, a TIMI 1 ﬂow
was achieved. Later manual thrombosuction with a thrombus-
ter catheter (Atrium, USA) was done. There was no signiﬁcant
increase in the ﬂow. At this point, intracoronary abciximab
(0.25 mg/kg) was also administered. Though initial better result
was seen with these steps, thrombus migration occurred
proximal to the ballooned segment (Video 3). Hence, we ended
up putting a soft wire across the big obtuse marginal branch.
Later, proximal part of LCX was dilated with another 3 mm
balloon (Fire Star, Cordis, Johnson and Johnson, USA). Though
we were not able to remove the clot completely even after
multiple attempts of thrombosuctions and balloon dilatations,
ﬁnal TIMI III ﬂow was achieved at this stage (Video 4). The
options available at that moment included proceeding with
stenting of the lesion, provision of intracoronary ﬁbrinolysis,
mechanical thrombosuction with angiojet system, or accepting
the end TIMI III ﬂow result. The option of placing a stent
across the lesion was not considered as the site was free of
atherosclerosis and stenting may be detrimental for the patient,
as it will increase the chance of stent thrombosis. As he has
already been loaded with dual antiplatelet pre-procedurally
(aspirin 325 mg, clopidogrel 600 mg) and has received Gp IIb/IIIa
inhibitor intraprocedurally, the chance of getting major bleeding
complication was considered to be high. Hence, intracoronary
ﬁbrinolysis was also avoided. Though we did not try mechanical
angiojet system for thrombosuction in our patient due to non-
availability of the same at that point of time, the patient became
pain-free with a TIMI III ﬂow in the culprit vessel. Hence, we
accepted the end result and stopped the procedure. Two days
later, the cine-ﬂuoroscopy showed the same ﬁndings of mildly
restricted leaﬂet motion. A trial of systemic ﬁbrinolysis with
tPA (100 mg for 2 h infusion) was attempted. Twelve hours later,
cine-ﬂuoroscopy was repeated which revealed normal leaﬂet
motion (Video 5). He was anticoagulated with heparin and
warfarin. A conventional angiogram done later showed a
presence of tiny thrombus in LCx (Fig. 3 and Video 6).
Fig. 3 – Left coronary angiogram in right anterior oblique
caudal view showing normally flowing arteries.
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Though the incidence of coronary embolism after prosthetic
valve surgeries is not clear, a recent large randomized study
has shown it to be <1%.1 Takenaka et al.2 suggested that
coronary embolism should be suspected whenever a possibili-
ty of multiple coronary arterial involvement is considered.
Most of the time, it affects the left coronary artery system3
especially distal epicardial and intra-mural branches of left
anterior descending artery as left circumﬂex takes a curve after
its origin. The prognosis of PHVT alone with coronary
embolism is dismal and is often fatal. In an extremely high-
risk candidate, systemic thrombolysis is usually preferred
while in the rest surgical thrombectomy with a coronary
bypass graft or a PCI is required. Mamby et al.4 ﬁrst attempted a
PCI in patient with coronary thromboembolism to LAD and
succeeded in decreasing the size of infarct by embolizing the
proximal thrombus distally. Kotooka et al.5 described three
cases of coronary embolism that was treated successfully by
PCI. Two of the three patients in their series had embolism in
RCA which was effectively treated by thrombosuction alone,
while the last one had a thrombus in left main coronary artery
that required stenting. All these patients had paroxysomal
atrial ﬁbrillation suggesting the left atrial appendage origin of
the thrombus. Marti et al.6 used heparin, intracoronary
alteplase, and abciximab along with PCI in the same setting
to succeed in restoring the ﬂow in the LCx, diagonal, and septal
arteries. Quinn et al.7 found that combination of intracoronary
abciximab and urokinase was beneﬁcial in a patient with a
partially successful PCI for coronary embolism in LAD and
diagonal branches after double valve replacement. Half dose
alteplase and prolonged tiroﬁban infusion were administered
to restore coronary blood ﬂow in LAD in a patient with failed
angiojet thrombosuction.8A high index of suspicion is required to diagnose coronary
embolism associated with PHVT. In this particular scenario
where the patient has undergone a Bentall's procedure with a
mechanical prosthetic valve for bicuspid valve related severe
aortic valve disease, we suggest to keep the possibilities of AD,
ACS and Boerhaave syndrome. The latter can be differentiated
from the former two by detailed history, while the initial two
differential diagnoses will mimic the same. Another clinical
possibility that should always be considered in patients with
prosthetic valve is infective endocarditis. History of fever, blood
culture, and presence of vegetations in TEE along with
inﬂammatory markers would be useful in such situation. We
would suggest to have trans-esophageal echocardiogram or CT
aortogram depending on the clinical status of the patient and
institutional preference. The treatment approaches include
surgery, pharmacological measures, and percutaneous inter-
vention.
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Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.ihj.2015.10.372.
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